Lynch Sendromlu Hastada Eş Zamanlı Endometrioid Endometrium Karsinomu Ve Tubal Kökenli Yüksek Dereceli Seröz Karsinom: Nadir Bir Senkron Malignite Varyantı

Ryan NAJ, Glaire MA, Blake D, Cabrera-Dandy M, Evans DG. The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis. Genet Med. 2019;21(10):2167–80.

Pal T, Permuth-Wey J, Sellers TA. A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer. Cancer. 2008;113(4):733–42.

Soslow RA, Han G, Park KJ, et al. Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma. Mod Pathol. 2012;25(4):625–36.

Rambau PF, Duggan MA, Ghatage P, et al. Significant frequency of MMR-deficiency in endometrioid ovarian carcinoma of patients under 50 years. Histopathology. 2016;69(3):412–20.

Vang R, Shih I-M, Kurman RJ. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms. Histopathology. 2013;62(1):44–58.

Jarboe EA, Folkins AK, Nucci MR, et al. Serous carcinogenesis in the fallopian tube: a descriptive classification. Int J Gynecol Pathol. 2008;27(1):1–9.

Broaddus RR, Lynch HT, Chen LM. Hereditary gynecologic cancers: differential diagnosis, surveillance, management, and the role of the pathologist. Am J Surg Pathol. 2006;30(5):560–78.

Stoffel EM, Mangu PB, Gruber SB, et al. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology clinical practice guideline endorsement of the familial risk–colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol. 2015;33(2):209–17.

Lu KH, Dinh M, Kohlmann W, et al. Gynecologic cancer as a “sentinel cancer” for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol. 2005;105(3):569–74.

Barrow BJ, Creasman WT. Management of endometrial cancer. Am J Obstet Gynecol. 2009;201(6):545–55.